Anti‑metastatic Effects of Aidi on Human Esophageal Squamous Cell Carcinoma by Inhibiting Epithelial‑mesenchymal Transition and Angiogenesis

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2018 May 12

PMID 29749455

Citations 16

Authors

Qingtong Shi

Yali Diao

Feng Jin

Zhiyan Ding

Affiliations

Soon will be listed here.

Abstract

Aidi injection, a proprietary Chinese medicine, has been widely used for the treatment of cancer. However, its effects and potential mechanism in esophageal squamous cell carcinoma (ESCC) have not yet been characterized. The aim of the present study was to identify the mechanism underlying the anti‑metastatic effects of treatment with Aidi. To test the effects and mechanism, EC9706 and KYSE70 cells were selected for in vitro experiments. In vivo, the anti‑metastatic effects of Aidi injection on a nude mouse peritoneal metastasis model were examined, and the mechanisms were assessed with immunohistochemical staining. A cell proliferation assay demonstrated that treatment with more than 3 mg/ml Aidi for 24 or 48 h significantly inhibited the proliferation of EC9706 (P<0.01) and KYSE70 cells (P<0.05, P<0.01). Subsequent experiments assessed cell migration, invasion and vasculogenic mimicry (VM) formation, with 5‑fluorouracil serving as a positive control. It was observed that treatment with Aidi inhibited cell migration, invasion and VM formation. Furthermore, it was identified that treatment with Aidi inhibited epithelial‑mesenchymal transition (EMT) signaling and the expression of vascular endothelial growth factor A (VEGF‑A) in EC9706 and KYSE70 cells, using western blotting. In the in vivo experiments, Aidi injection effectively suppressed tumor metastasis in the mouse tumor model. Additionally, the expression of vimentin and vascular endothelial growth factor was decreased, and the expression of cadherin‑1 was increased in the tumor tissue. The present results suggested that treatment with Aidi may inhibit tumor metastasis in ESCC through the inhibition of EMT signaling and angiogenesis.

Citing Articles

Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.

Zhang J, Yang S, Chen X, Zhang F, Guo S, Wu C Chin Med. 2025; 20(1):2.

PMID: 39754146 PMC: 11699780. DOI: 10.1186/s13020-024-01054-1.

Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.

Gao W, Zhang K J Cancer Res Clin Oncol. 2023; 149(12):9823-9838.

PMID: 37246189 DOI: 10.1007/s00432-023-04892-y.

Efficacy of Aidi injection combined with chemotherapy, radiotherapy or chemoradiotherapy for unresectable esophageal cancer treatment: A meta-analysis and systematic review of 29 randomized controlled trials based on Asian populations (China).

Huang J, Fan T, Rong Y, Li X, Jiang Q, Kan J Eur J Clin Pharmacol. 2023; 79(6):707-722.

PMID: 37043012 DOI: 10.1007/s00228-023-03493-5.

Natural Products for Esophageal Cancer Therapy: From Traditional Medicine to Modern Drug Discovery.

An J, An S, Choi M, Jung J, Kim B Int J Mol Sci. 2022; 23(21).

PMID: 36362345 PMC: 9657766. DOI: 10.3390/ijms232113558.

How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?.

Kirdeeva Y, Fedorova O, Daks A, Barlev N, Shuvalov O Pharmaceuticals (Basel). 2022; 15(7).

PMID: 35890166 PMC: 9320176. DOI: 10.3390/ph15070868.

References

Tao W, Luo X, Cui B, Liang D, Wang C, Duan Y . Practice of traditional Chinese medicine for psycho-behavioral intervention improves quality of life in cancer patients: A systematic review and meta-analysis. Oncotarget. 2015; 6(37):39725-39. PMC: 4741858. DOI: 10.18632/oncotarget.5388. View

Zhang L, Ma J, Han Y, Liu J, Zhou W, Hong L . Targeted therapy in esophageal cancer. Expert Rev Gastroenterol Hepatol. 2016; 10(5):595-604. DOI: 10.1586/17474124.2016.1140036. View

Xiao Z, Liang R, Wang C, Xu S, Li N, He Y . Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer?: A meta-analysis of 16 randomized controlled trials following the PRISMA guidelines. Medicine (Baltimore). 2016; 95(35):e4517. PMC: 5008545. DOI: 10.1097/MD.0000000000004517. View

Jiancheng W, Long G, Ye Z, Jinlong L, Pan Z, Lei M . Effect of Aidi injection plus chemotherapy on gastric carcinoma: a Meta-analysis of randomized controlled trials. J Tradit Chin Med. 2015; 35(4):361-74. DOI: 10.1016/s0254-6272(15)30111-4. View

Lou H, Pan H, Jin W . [Clinical study on treatment of primary liver cancer by Aidi injection combined with cool-tip radiofrequency ablation]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007; 27(5):393-5. View

Domper Arnal M, Ferrandez Arenas A, Lanas Arbeloa A . Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015; 21(26):7933-43. PMC: 4499337. DOI: 10.3748/wjg.v21.i26.7933. View

Wang Q, He X, Tian J, Wang X, Ru P, Ruan Z . [A meta analysis of aidi injection plus taxotere and cisplatin in the treatment of non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi. 2010; 13(11):1027-34. PMC: 6000489. DOI: 10.3779/j.issn.1009-3419.2010.11.06. View

Li S, Qin X, Chai S, Qu C, Wang X, Zhang H . Modulation of E-cadherin expression promotes migration ability of esophageal cancer cells. Sci Rep. 2016; 6:21713. PMC: 4761978. DOI: 10.1038/srep21713. View

Gianni-Barrera R, Trani M, Fontanellaz C, Heberer M, Djonov V, Hlushchuk R . VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting. Angiogenesis. 2012; 16(1):123-36. DOI: 10.1007/s10456-012-9304-y. View

10.

Che N, Zhao X, Sun T, Zhao X, Gu Q, Dong X . The role of Twist1 in hepatocellular carcinoma angiogenesis: a clinical study. Hum Pathol. 2011; 42(6):840-7. DOI: 10.1016/j.humpath.2010.03.010. View

11.

Liu Z, Sun B, Qi L, Li H, Gao J, Leng X . Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition. Cancer Sci. 2012; 103(4):813-20. PMC: 7659366. DOI: 10.1111/j.1349-7006.2011.02199.x. View

12.

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

13.

Liu Y, Zhang W, Wang X, Liu S . Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts. BMC Complement Altern Med. 2014; 14:228. PMC: 4105135. DOI: 10.1186/1472-6882-14-228. View

14.

Zeng H, Zheng R, Zhang S, Zuo T, Xia C, Zou X . Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries. Thorac Cancer. 2016; 7(2):232-7. PMC: 4773307. DOI: 10.1111/1759-7714.12322. View

15.

Yu J, Zhang Y, Leung L, Liu L, Yang F, Yao X . Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis. J Hematol Oncol. 2016; 9(1):111. PMC: 5070169. DOI: 10.1186/s13045-016-0340-8. View

16.

Robert J . [Biology of cancer metastasis]. Bull Cancer. 2013; 100(4):333-42. DOI: 10.1684/bdc.2013.1724. View

17.

Xu X, Ling Z, Chen W, Xu Y, Mao W . The overexpression of VEGF in esophageal cancer is associated with a more advanced TMN stage: a meta-analysis. Cancer Biomark. 2013; 13(2):105-13. DOI: 10.3233/CBM-130343. View

18.

Xiao Z, Wang C, Chen L, Tang X, Li L, Li N . Has aidi injection the attenuation and synergistic efficacy to gemcitabine and cisplatin in non-small cell lung cancer? A meta-analysis of 36 randomized controlled trials. Oncotarget. 2016; 8(1):1329-1342. PMC: 5352058. DOI: 10.18632/oncotarget.13617. View

19.

Ji Z, Huang X, Wu X, Liu J, Wang L, Tang J . Safety of Brucea javanica and cantharidin combined with chemotherapy for treatment of NSCLC patients. Asian Pac J Cancer Prev. 2014; 15(20):8603-5. DOI: 10.7314/apjcp.2014.15.20.8603. View

20.

Jain R, Gupta S, Pasricha N, Faujdar M, Sharma M, Mishra P . ESCC with metastasis in the young age of caustic ingestion of shortest duration. J Gastrointest Cancer. 2010; 41(2):93-5. DOI: 10.1007/s12029-009-9121-8. View